Publications

Mittal D, Young A, Stannard K, Yong M, Teng MW, Allard B, Stagg J, Smyth MJ. Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor. Cancer Res. 2014 Jul 1. [Epub ahead of print]

Schuessler A, Smith C, Beagley L, Boyle GM, Rehan S, Matthews K, Jones L, Crough T, Dasari V, Klein K, Smalley A, Alexander H, Walker DG, Khanna R. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. Cancer Res. 2014 Jul 1;74(13):3466-76.

Liu YC, Chen Z, Neller MA, Miles JJ, Purcell AW, McCluskey J, Burrows SR, Rossjohn J, Gras S. A Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen Micropolymorphism. J Biol Chem. 2014 Jun 13;289(24):16688-16698.

West AC, Smyth MJ, Johnstone RW. The anticancer effects of HDAC inhibitors require the immune system. Oncoimmunology. 2014 Jan 1;3(1):e27414.

Murat P, Zhong J, Lekieffre L, Cowieson NP, Clancy JL, Preiss T, Balasubramanian S, Khanna R, Tellam J. G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation. Nat Chem Biol. 2014 May;10(5):358-64.

Beavis PA, Milenkovski N, Stagg J, Smyth MJ, Darcy PK. A2A blockade enhances anti-metastatic immune responses. Oncoimmunology. 2013 Dec 1;2(12):e26705. Epub 2013 Oct 22.

Smith C, Gras S, Brennan RM, Bird NL, Valkenburg SA, Twist KA, Burrows JM, Miles JJ, Chambers D, Bell S, Campbell S, Kedzierska K, Burrows SR, Rossjohn J, Khanna R. Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire. Sci Rep. 2014 Feb 10;4:3993. doi: 10.1038/srep03993.

Khanna R, Smith C. Cellular immune therapy for viral infections in transplant patients. Indian J Med Res. 2013 Nov;138(5):796-807. Review.

Bookmark and Share